Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.

The incidence of stroke and dementia are diverging across the world, rising for those in low-and middle-income countries and falling in those in high-income countries. This suggests that whatever factors cause these trends are potentially modifiable. At the population level, neurological disorders as a group account for the largest proportion of disability-adjusted life years globally (10%). Among neurological disorders, stroke (42%) and dementia (10%) dominate. Stroke and dementia confer risks for each other and share some of the same, largely modifiable, risk and protective factors. In principle, 90% of strokes and 35% of dementias have been estimated to be preventable. Because a stroke doubles the chance of developing dementia and stroke is more common than dementia, more than a third of dementias could be prevented by preventing stroke. Developments at the pathological, pathophysiological, and clinical level also point to new directions. Growing understanding of brain pathophysiology has unveiled the reciprocal interaction of cerebrovascular disease and neurodegeneration identifying new therapeutic targets to include protection of the endothelium, the blood-brain barrier, and other components of the neurovascular unit. In addition, targeting amyloid angiopathy aspects of inflammation and genetic manipulation hold new testable promise. In the meantime, accumulating evidence suggests that whole populations experiencing improved education, and lower vascular risk factor profiles (e.g., reduced prevalence of smoking) and vascular disease, including stroke, have better cognitive function and lower dementia rates. At the individual levels, trials have demonstrated that anticoagulation of atrial fibrillation can reduce the risk of dementia by 48% and that systolic blood pressure lower than 140 mmHg may be better for the brain. Based on these considerations, the World Stroke Organization has issued a proclamation, endorsed by all the major international organizations focused on global brain and cardiovascular health, calling for the joint prevention of stroke and dementia. This article summarizes the evidence for translation into action. © 2019 the Alzheimer's Association and the World Stroke Organisation. Published by Elsevier Inc. All rights reserved.

[1]  B. Norrving,et al.  Helsingborg Declaration 2006 on European Stroke Strategies , 2006, Cerebrovascular Diseases.

[2]  R. Righart,et al.  Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts , 2015, Neurology.

[3]  V. Hachinski,et al.  The reciprocal risks of stroke and cognitive impairment in an elderly population , 2006, Alzheimer's & Dementia.

[4]  J. Wardlaw,et al.  Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.

[5]  Zhen Zhao,et al.  Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.

[6]  J. Wardlaw,et al.  Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions , 2015, International journal of stroke : official journal of the International Stroke Society.

[7]  K. Rhodes,et al.  The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.

[8]  G. Wang,et al.  Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response , 2018, Nature Neuroscience.

[9]  C. Iadecola,et al.  Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. , 2016, The Journal of clinical investigation.

[10]  George A. Carlson,et al.  Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor Protein , 2002, Neurobiology of Disease.

[11]  J. de Pina-Cabral World , 2005, Science.

[12]  Denise C. Park,et al.  Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. , 2013, JAMA neurology.

[13]  W. Hacke,et al.  Implementing the proclamation of stroke and potentially preventable dementias , 2018, Journal of clinical hypertension.

[14]  D. Llewellyn,et al.  Stroke and dementia risk: A systematic review and meta-analysis , 2018, Alzheimer's & Dementia.

[15]  A. Levey,et al.  Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically , 2008, BMC Neuroscience.

[16]  M. Rosenqvist,et al.  Less dementia with oral anticoagulation in atrial fibrillation , 2018, European heart journal.

[17]  C. DeCarli,et al.  Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging , 2018, JAMA neurology.

[18]  Ivy Shiue,et al.  Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet Neurology.

[19]  Lei Yu,et al.  Person‐specific contribution of neuropathologies to cognitive loss in old age , 2018, Annals of neurology.

[20]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[21]  V. Hachinski,et al.  Progressive Increase in Infarct Size, Neuroinflammation, and Cognitive Deficits in the Presence of High Levels of Amyloid , 2007, Stroke.

[22]  C. Iadecola,et al.  Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.

[23]  L. Donini,et al.  Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review. , 2018, Journal of Alzheimer's disease : JAD.

[24]  V. Hachinski,et al.  Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: Inflammatory Responses , 2005, Stroke.

[25]  Thomas Wisniewski,et al.  Clearance systems in the brain—implications for Alzheimer disease , 2015, Nature Reviews Neurology.

[26]  T. Bak,et al.  Bilingualism delays age at onset of dementia, independent of education and immigration status , 2013, Neurology.

[27]  C. Iadecola,et al.  Cyclooxygenase 1–Derived Prostaglandin E2 and EP1 Receptors Are Required for the Cerebrovascular Dysfunction Induced by Angiotensin II , 2010, Hypertension.

[28]  Joanna Wardlaw,et al.  Action Plan for Stroke in Europe 2018–2030 , 2018, European stroke journal.

[29]  C. Iadecola,et al.  Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals , 2004, Circulation research.

[30]  Andrew Gibson,et al.  Impaired behavioural flexibility related to white matter microgliosis in the TgAPP21 rat model of Alzheimer disease , 2019, Brain, Behavior, and Immunity.

[31]  D. Stuss,et al.  Subcortical hyperintensity volumetrics in Alzheimer’s disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory , 2014, Alzheimer's Research & Therapy.

[32]  Quanzheng Li,et al.  Neurogenetic contributions to amyloid beta and tau spreading in the human cortex , 2018, Nature Medicine.

[33]  Webb Ajs.,et al.  Action Plan for Stroke in Europe , 2018 .

[34]  Keith A. Johnson,et al.  Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex , 2017, JAMA neurology.

[35]  J. Bond,et al.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.

[36]  B. Zlokovic,et al.  Hypertension Induces Brain &bgr;-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature , 2012, Hypertension.

[37]  Thorbjørn S. Engedal,et al.  Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  V. Hachinski Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.

[39]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[40]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[41]  Andrei G. Vlassenko,et al.  Loss of Brain Aerobic Glycolysis in Normal Human Aging. , 2017, Cell metabolism.

[42]  C. Iadecola,et al.  Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Ping Zhou,et al.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.

[44]  A. Thiel,et al.  Neuroimaging in vascular cognitive impairment: a state-of-the-art review , 2016, BMC Medicine.

[45]  Myriam Peyrounette,et al.  Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models , 2018, Nature Neuroscience.

[46]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[47]  Z. Khachaturian The role of calcium regulation in brain aging: reexamination of a hypothesis , 1989, Aging.

[48]  Kim Mouridsen,et al.  Capillary Dysfunction: Its Detection and Causative Role in Dementias and Stroke , 2015, Current Neurology and Neuroscience Reports.

[49]  J. Pierce,et al.  Innate immunity receptor CD36 promotes cerebral amyloid angiopathy , 2013, Proceedings of the National Academy of Sciences.

[50]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[51]  Keith A. Johnson,et al.  Interactive Associations of Vascular Risk and &bgr;-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study , 2018, JAMA neurology.

[52]  C. Brayne,et al.  A commentary on studies presenting projections of the future prevalence of dementia , 2013, BMC Public Health.

[53]  D. Stuss,et al.  Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease , 2017, Alzheimer's & Dementia.

[54]  V. Hachinski,et al.  Multimodal Imaging of White Matter Inflammation in a Rat Model of Striatal Ischemic Stroke (P2.226) , 2018 .

[55]  Alan J. Thomas,et al.  TDP‐43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing , 2017, Brain pathology.

[56]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[57]  Norbert Schuff,et al.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.

[58]  C. Naus,et al.  Comorbid Rat Model of Ischemia and β‐Amyloid Toxicity: Striatal and Cortical Degeneration , 2015, Brain pathology.

[59]  V. Hachinski,et al.  Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: II. Effects of Triflusal , 2005, Stroke.

[60]  V. Hachinski,et al.  Effects of pyrrolidine dithiocarbamate on beta-amyloid (25–35)-induced inflammatory responses and memory deficits in the rat , 2006, Neurobiology of Disease.

[61]  C. Iadecola,et al.  The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. , 2011, American journal of physiology. Heart and circulatory physiology.

[62]  V. Hachinski Dementia: Paradigm shifting into high gear , 2019, Alzheimer's & Dementia.

[63]  Eric E. Smith,et al.  Vascular dysfunction—The disregarded partner of Alzheimer's disease , 2019, Alzheimer's & Dementia.

[64]  C. Iadecola The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.

[65]  Ken Arai,et al.  Pathophysiologic Cascades in Ischemic Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.

[66]  B. Zlokovic,et al.  Blood-Brain Barrier: From Physiology to Disease and Back. , 2019, Physiological reviews.

[67]  Suvarna Alladi,et al.  World dementia , 2018, Neurology.

[68]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[69]  L. Robinson,et al.  A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II , 2016, Nature Communications.

[70]  U. Yoon,et al.  Cortical thinning in subcortical vascular dementia with negative 11C-PiB PET. , 2012, Journal of Alzheimer's disease : JAD.

[71]  S. Black,et al.  Global hemispheric CT hypoperfusion may differentiate headache with associated neurological deficits and lymphocytosis from acute stroke. , 2008, Stroke.

[72]  V. Hachinski,et al.  Behavioural inflexibility in a comorbid rat model of striatal ischemic injury and mutant hAPP overexpression , 2017, Behavioural Brain Research.

[73]  Henrik Zetterberg,et al.  Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity , 2017, Nature Communications.

[74]  Alan C. Evans,et al.  Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.

[75]  Arthur W. Toga,et al.  Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.

[76]  C. Iadecola,et al.  Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.

[77]  C. Iadecola,et al.  Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Keith A. Johnson,et al.  Vascular Risk and β‐Amyloid Are Synergistically Associated with Cortical Tau , 2019, Annals of neurology.

[79]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[80]  C. Iadecola,et al.  Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. , 2003, American journal of physiology. Heart and circulatory physiology.

[81]  Piero Antuono,et al.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.

[82]  C. Iadecola,et al.  Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  Z. Khachaturian Calcium Hypothesis of Alzheimer's Disease and Brain Aging a , 1994, Annals of the New York Academy of Sciences.

[84]  S. Whitehead,et al.  Differential Anatomical Expression of Ganglioside GM1 Species Containing d18:1 or d20:1 Sphingosine Detected by MALDI Imaging Mass Spectrometry in Mature Rat Brain , 2015, Front. Neuroanat..

[85]  A. Fagan,et al.  Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction , 2018, Nature Medicine.

[86]  D. Na,et al.  Increased Uptake of AV-1451 in a Subacute Infarction Lesion , 2018, Yonsei medical journal.

[87]  Brian Levine,et al.  Lesion Explorer: A comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue , 2011, NeuroImage.

[88]  T. Bak,et al.  Dementia in developing countries: Does education play the same role in India as in the West? , 2014, Dementia & neuropsychologia.

[89]  V. Hachinski,et al.  Declining Incidence of Stroke and Dementia: Coincidence or Prevention Opportunity? , 2015, JAMA neurology.

[90]  D. Borchelt,et al.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.

[91]  M. Kivipelto,et al.  Dementia risk in renal dysfunction , 2017, Neurology.

[92]  D. Cornfield,et al.  A beta-peptides enhance vasoconstriction in cerebral circulation. , 2001, American journal of physiology. Heart and circulatory physiology.

[93]  B. Zlokovic,et al.  Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.

[94]  Leif Østergaard,et al.  The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[95]  C. Iadecola,et al.  The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction , 2014, Nature Communications.

[96]  Arthur W Toga,et al.  The role of brain vasculature in neurodegenerative disorders , 2018, Nature Neuroscience.

[97]  M. Dichgans,et al.  Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.

[98]  W. Hacke,et al.  Implementing the Proclamation of Stroke and Potentially Preventable Dementias , 2018, International journal of stroke : official journal of the International Stroke Society.

[99]  I. McKeith,et al.  Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study , 2009, PLoS medicine.

[100]  J. Trojanowski,et al.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.

[101]  B. Lawlor,et al.  Review: Blood pressure and dementia — a comprehensive review , 2009, Therapeutic advances in neurological disorders.

[102]  Monique M. B. Breteler,et al.  The changing prevalence and incidence of dementia over time — current evidence , 2017, Nature Reviews Neurology.

[103]  M. Dichgans,et al.  Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke , 2018, Neurology.

[104]  Z. Khachaturian,et al.  Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.

[105]  M. Dichgans,et al.  Serum neurofilament light , 2018, Neurology.

[106]  C. Iadecola The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.

[107]  V. Hachinski,et al.  APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts , 2018, Journal of Neuroinflammation.

[108]  Alan C. Evans,et al.  Multimodal imaging-based therapeutic fingerprints for optimizing personalized interventions: Application to neurodegeneration , 2018, NeuroImage.

[109]  Rikesh M. Rajani,et al.  Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats , 2018, Science Translational Medicine.

[110]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[111]  Arne Møller,et al.  Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease , 2017, Alzheimer's & Dementia.

[112]  S. Pendlebury,et al.  Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.

[113]  Kim Mouridsen,et al.  Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study , 2017, Neurobiology of Aging.

[114]  I. Aboderin,et al.  Stroke management in Europe , 1996 .

[115]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[116]  Martin Dichgans,et al.  Vascular cognitive impairment , 2017, Journal of the Neurological Sciences.

[117]  D. Werring,et al.  Outcome markers for clinical trials in cerebral amyloid angiopathy , 2001, The Lancet Neurology.

[118]  P. Gorelick,et al.  Risk Factors for Vascular Dementia and Alzheimer Disease , 2004, Stroke.

[119]  A. Rahmim,et al.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.

[120]  V. Hachinski,et al.  Concomitant vascular and neurodegenerative pathologies double the risk of dementia , 2018, Alzheimer's & Dementia.

[121]  C. Iadecola,et al.  Estrous Cycle–Dependent Neurovascular Dysfunction Induced by Angiotensin II in the Mouse Neocortex , 2009, Hypertension.

[122]  Kim Mouridsen,et al.  The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[123]  Ping Zhou,et al.  Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer A&bgr; Peptides , 2017, Circulation research.

[124]  V. Hachinski,et al.  Population-based stroke and dementia incidence trends: Age and sex variations , 2017, Alzheimer's & Dementia.

[125]  D. Cornfield,et al.  Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .

[126]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[127]  C. DeCarli,et al.  Impact of multiple pathologies on the threshold for clinically overt dementia , 2017, Acta Neuropathologica.

[128]  Madelaine Daianu,et al.  Pericyte degeneration causes white matter dysfunction in the mouse central nervous system , 2018, Nature Medicine.

[129]  V. Hachinski,et al.  Characterization of Behaviour and Remote Degeneration Following Thalamic Stroke in the Rat , 2015, International journal of molecular sciences.

[130]  Henning U Voss,et al.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function , 2018, Nature Communications.